help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 20, 2005
Endocrinology, doi:10.1210/en.2004-0886
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/4/2091    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romeo, R. D.
Right arrow Articles by McEwen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romeo, R. D.
Right arrow Articles by McEwen, B. S.

Submitted on July 12, 2004
Accepted on October 25, 2004

Dihydrotestosterone increases hippocampal NMDA binding but does not affect choline acetyltransferase cell number in the forebrain or choline transporter levels in the CA1 region of adult male rats

Russell D. Romeo*, Daniel Staub, Aaron M. Jasnow, Ilia N. Karatsoreos, Janice E. Thornton, and Bruce S. McEwen

Laboratory of Neuroendocrinology, The Rockefeller University, New York, NY 10021; Neuroscience Program, Oberlin College, Oberlin, OH 44704; Laboratory of Neurobiology and Behavior, The Rockefeller University, New York, NY 10021; Department of Psychology, Columbia University, New York, NY 10027

* To whom correspondence should be addressed. E-mail: romeor{at}rockefeller.edu.

Testosterone, acting through its androgenic metabolite 5{alpha}-dihydrotestosterone (DHT), can increase dendritic spine density in the CA1 region of the male rat hippocampus. The mechanisms mediating this increase in spines are presently unknown. In female rats, estrogen (E) has been shown to increase spine density, which is in part mediated by increases in NMDA receptors in the CA1 region and cholinergic forebrain inputs to the hippocampus. Whether similar mechanisms are responsible for the DHT-induced increase in spines in the male remains to be determined. In the first experiment, we used [3H] glutamate NMDA receptor binding autoradiography to assess whether DHT-treated males had higher NMDA receptor levels in the CA1 region of the hippocampus compared with oil-treated males. In the second set of experiments, we used choline acetyltransferase (ChAT) in situ hybridization and immunohistochemistry to assess whether DHT could affect ChAT cell number in the forebrain. We also investigated the effect of DHT on hemicholinium-3-sensitive choline transporter (CHT) levels in the CA1 region of the male hippocampus. We found that DHT significantly increased NMDA receptor binding in the CA1 region of males, but had no effect on ChAT cell number in the forebrain or CHT protein levels in the CA1 region. These data indicate that, similar to E-induced spinogenesis in females, DHT-induced increases in spine formation in males may require increases in NMDA receptors. However, unlike E-treated females, these data suggest that DHT does not influence cholinergic inputs to the hippocampus.


Key words: Dihydrotestosterone • NMDA receptors • ChAT • choline transporter • CHT




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Goel and T. L. Bale
Organizational and Activational Effects of Testosterone on Masculinization of Female Physiological and Behavioral Stress Responses
Endocrinology, December 1, 2008; 149(12): 6399 - 6405.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society